Approved Documents
DTC Supplement
2008
| December | Issue 85 |
SMC Advice Issued in December
2008 Aripiprazole solution Atazanavir Bivalirudin powder Flecainide acetate Methylnaltrexone solution Miconazole muco-adhesive buccal Rivaroxaban Updates from previous SMC advice Anidulafungin powder and solvent Micafungin Pegylated interferon TAPG Update Fondaparinux Treatment Protocol - Anticoagulation of patients with Acute Coronary Syndrome (ACS) Forthcoming SMC Advice |
| November | Issue 84 |
SMC Advice Issued in November
2008 Ambrisentan tablets Anidulafungin powder and solvent Bosentan Icatibant solution Insulin glulisine solution Insulin lispro solution Insulin lispro KwikPen Quetiapine prolonged release Rufinamide TAPG Update Forthcoming SMC Advice |
| October | Issue 83 |
SMC Advice Issued in October
2008 Capecitabine Cinacalcet Dexrazoxane Duloxetine Fosaprepitant dimeglumine Maraviroc Pegylated liposomal doxorubicin Salbutamol sulphate Sitagliptin TAPG Update Accessing the Tayside Area Prescribing Guide (TAPG) Forthcoming SMC Advice |
| Aug/Sept | Issue 82 |
SMC Advice Issued in
August/September 2008 Aripiprazole orodispersible tablets:oral solution Alemtuzumab concentrate for solution for infusion Buprenorphine transdermal patches Clobetasol propionate shampoo Ibritumomab tiuxetan Lidocaine medicated plaster Micafungin power for solution for infusion Melatonin prolonged-release tablets Pegylated interferon power Pemetrexed powder Rabbit anti-human thymocyte immunoglobulin power Rituximab concentrate for solution for infusion Ropinirole prolonged-release tablers Temsirolimus Teriparatide Trabectedin concentrate for solution for infusion Venlafaxine TAPG Update Proposal to recommend restricted use of metformin modified release within Tayside Forthcoming SMC Advice |
| July | Issue 81 |
SMC Advice Issued in July 2008 Docetaxel Ferric carboxymaltose Fesoterodine fumarate Paricalcitol IV Paricalcitol capsules Sorafenib Tenofovir disoproxil fumarate Vildaglliptin/metformin Updates from previous SMC Advice Bevacizumab - renal cell cancer Bevacizumab - colorectal cancer Clostridium botulinum neurotoxin Type A Panitumumab TAPG Update Exenatide protocol Dyloject protocol Infliximab for ankylosing spondylitis - change in local recommendation Rotigotine patches - new storage conditions Forthcoming SMC Advice |
| June | Issue 80 |
SMC Advice Issued in June 2008 Adalimumab Anidulafungin Bevacizumab Bosentan Clostridium botulinum neurotoxin Type A Dabigatran etexilate Epoetin zeta Glucosamine hydrochloride Lidocaine Loteprednol etabonate Nilotinib Panitumumab Perindopril arginine Perindopril arginine/indapamide Teriparatide TAPG Update Forthcoming SMC Advice |
| May | Issue 79 |
SMC Advice Issued in May 2008 Aliskiren Escitalopram Imiquimod Lenalidomide Raltegravir Updates from previous SMC advice in March/April 2008 Daptomycin Efavirenz, emtricitabine, tenofovir Nelarabine Telbivudine TAPG Update Bisphosphonates in post-menopausal osteoporosis: an update Forthcoming SMC Advice |
| Apr | Issue 78 |
SMC Advice Issued in April
2008 Efavirenz, emtricitabine, tenofovir Insulin glargine Insulin glulisine Maraviroc Methoxy polyethylene glycol-epoetin beta Nelarabine Paliperidone prolonged-release tablets Retapamulin Vildagliptin TAPG Update Switch to Levobupivacaine Forthcoming SMC Advice |
| Mar | Issue 77 |
SMC Advice Issued in February
and March
2008 Clobetasol propionate 0.05% shampoo Colesevelam hydrochloride Daptomycin 350mg & 500mg vials Diclofenac injection Follitropin alfa Fondaparinux sodium - ST Glyceryl trinitrate 0.4% Infliximab 100mg powder for infusion Leviteracetam - adjunctive therapy partial onset seizures Leviteracetam - adjunctive therapy myoclonic seizures Leviteracetam - adjunctive therapy tonic-clonic seizures Leviteracetam - monotherapy partial onset seizures Losartan 100mg/hydrochlorothiazide 12.5mg Mesalazine - moderate acute exacerbations Mesalazine - mild acute exacerbations Mesalazine - maintenance of remission Mesalazine - remission Pemetrexed Salmeterol/fluticasone inhaler Telbivudine Trabectedin Valsartan Zoledronic acid TAPG Update Eplerenone Update Minor Ailments Scheme Formulary Oramorph liquid unit dose vials (UDVs) discontinuation Forthcoming SMC Advice |
| Jan | Issue 76 |
SMC Advice Issued in January
2008 Beclometasone, formoterol MDI Latanoprost, timolol eye drops Standardised allergen extract of grass pollen from Timothy TAPG Update Natalixumab update Methadone 5mg/ml Formulation - not recommended in Tayside Symptomatic Relief Policy Update SMC Briefing Note Forthcoming SMC Advice |
Home | TAPG | New Medicines | Policies | Links